# Molecular Profiling After Neoadjuvant Chemotherapy for Triple-negative Breast Cancer

> **NCT04362462** · — · UNKNOWN · sponsor: **Texas Tech University Health Sciences Center, El Paso** · enrollment: 120 (estimated)

## Conditions studied

- Triple-negative Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04362462
- **Lead sponsor:** Texas Tech University Health Sciences Center, El Paso
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-05
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2020-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04362462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04362462, "Molecular Profiling After Neoadjuvant Chemotherapy for Triple-negative Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04362462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*